Tajikistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Health News.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 31, 2025

Dec. 31, 2025

Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

Dec. 31, 2025

LuluTox Detox Tea Unveiled: Why Lulutox Tea Being Discussed as the Best Herbal Weight Loss Tea Blend for Women to Burn Fat in 2026

GlobeNewswire

Dec. 31, 2025

Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD

GlobeNewswire

Dec. 31, 2025

Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

GlobeNewswire

Dec. 31, 2025

River Oaks Treatment Center Offers Expanded Mental Health Services as the New Year Brings Increased Focus on Wellness

GlobeNewswire

Dec. 31, 2025

Laguna Treatment Center Strengthens Clinical Team with New Behavioral Health Therapist

GlobeNewswire

Dec. 31, 2025

New Year, New Mission: Oxford Treatment Center Empowers Veterans to Reclaim Their Lives in 2026

GlobeNewswire

Dec. 31, 2025

Valneva et le Serum Institute of India annoncent la fin de leur accord de licence pour le vaccin contre le chikungunya

GlobeNewswire

Dec. 31, 2025

Total number of shares and voting rights in Zealand Pharma as of December 31, 2025

GlobeNewswire

Dec. 31, 2025

BioNTX Marks the Close of the First Quarter of the 21st Century with Growth, Workforce Momentum, and Innovation Leadership

GlobeNewswire

Dec. 31, 2025

Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

Dec. 31, 2025

Why Most New Year’s Resolutions Fail by January—And How to Make Them Stick in 2026

GlobeNewswire

Dec. 31, 2025

Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins

GlobeNewswire

Dec. 31, 2025

Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders

GlobeNewswire

Dec. 31, 2025

Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders

GlobeNewswire

Dec. 31, 2025

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

GlobeNewswire

Dec. 31, 2025

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

GlobeNewswire

Dec. 31, 2025

Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

GlobeNewswire

Dec. 31, 2025

Aiwibi Launches International Initiative to Support Preterm Infant Care

GlobeNewswire

Dec. 31, 2025

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

GlobeNewswire